Diffuse interstitial or replacement myocardial fibrosis is a common feature of a broad variety
of cardiomyopathies. Myocardial fibrosis leads to impaired cardiac diastolic and systolic …

The writing committee consisted of acknowledged experts in the field of CMR, as well as a
liaison from the ACCF Task Force on Clinical ECDs, the oversight group for this document …

Background—Late gadolinium enhancement (LGE) by cardiac MR (CMR) is a predictor of
adverse cardiovascular outcomes in patients with nonischemic cardiomyopathy (NICM) …

Catheter ablation is now an important option to control recurrent ventricular tachycardias
(VTs). The field has evolved rapidly and is a work in progress. Ablation is often a sole …

Objectives: We studied the prognostic implications of midwall fibrosis in dilated
cardiomyopathy (DCM) in a prospective longitudinal study. Background: Risk stratification of …

This international consensus statement of the European Heart Rhythm Association (EHRA),
Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society is intended to provide …

Noninvasive imaging plays a central role in the diagnosis of heart failure, assessment of
prognosis, and monitoring of therapy. Cardiovascular magnetic resonance (CMR) offers a …

Background—Accurate risk stratification is crucial for effective treatment planning after
myocardial infarction (MI). Previous studies suggest that the peri-infarct border zone may be …

Objectives: We examined whether the presence and extent of late gadolinium enhancement
(LGE) by cardiovascular magnetic resonance (CMR) predict adverse outcomes in …

Objectives: Our aim was to determine whether myocardial fibrosis, detected by
cardiovascular magnetic resonance (CMR), represents an arrhythmogenic substrate in …